A leaking pipe above a chemistry analyzer isn’t just a facilities issue—it’s a patient-care risk. In MLO’s October #LabInnovator Q&A, Jody Dalberg, MLS (ASCP)ꟲᴹ, shares how his team made the case for a new lab and improved workflows. 🔬 Read more: mlo-online.com/management/ca…

A reported HbA1c value may not tell the whole story. Learn how hemoglobin variants, elevated HbF, and chromatogram review can affect HbA1c testing. Join Dr. Kuanysh Kabytaev Nov. 10 for a free CE webinar. Register: ce.mlo-online.com/beyond-the…

Decentralizing molecular testing raises important questions about QC, regulatory requirements, test utilization, and patient outcomes. Join Dr. Kenneth Gavina on Oct. 28 for a free MLO webinar and earn 1 CE credit. Register: ce.mlo-online.com/to-central…

TOMORROW: This webinar reviews regulatory requirements and consensus standards for full-process quality control in clinical flow cytometry laboratories, highlighting how to monitor the pre-analytic and analytic variables that can affect patient results: ce.mlo-online.com/full-proce…

Centralized or decentralized molecular infectious disease testing—which approach best meets your lab's needs? Explore the clinical, operational, and financial considerations with Dr. Kenneth Gavina in this free CE webinar on Oct. 28. Register: ce.mlo-online.com/to-central…

Are routine QC checks enough to monitor the full clinical flow cytometry testing process? Join MLO on Oct. 20 for a free live CE webinar on regulatory requirements and practical approaches to full-process quality control. Register: bit.ly/4i2zu64

BNP and NT-proBNP are well established in heart failure diagnosis—but could they tell us more? This October CE article explores their prognostic value and what these biomarkers may reveal about future cardiovascular risk: bit.ly/4ATx7Lp #LaboratoryMedicine #HeartFailure

What do ENA concordance numbers really tell laboratories? This analysis takes a closer look at assay validation, study design, platform variability, and what the data mean for labs evaluating ENA testing options: bit.ly/4ycSuoH #AutoimmuneDisease #ClinicalLab #Immunology

Choosing a hemostasis analyzer involves more than comparing speed and price. This Q&A explores what labs should consider when evaluating real-world performance, automation, workflow, support, and long-term value: bit.ly/4yLI5RG

A new diagnostic test may offer little value if it’s simply added to an existing protocol. Explore how a Texas hospital redesigned its sepsis workflow around a rapid host-response test—and what the experience means for other laboratories: bit.ly/3TtatsJ.

Overlapping symptoms can make women’s health diagnoses challenging. Explore how molecular workflows can support comprehensive testing, greater efficiency, and more actionable results for clinical decision-making: bit.ly/46K16b7 #MolecularDiagnostics #ClinicalLaboratory

High throughput is only part of the equation for today’s clinical laboratories. Explore how analyzer scalability, uptime, maintenance, and workflow efficiency can affect laboratory operations as testing demands grow: bit.ly/4Am5YRc

Explore how combining ANA with disease-specific autoantibodies may improve diagnostic accuracy and support earlier evaluation: bit.ly/4iTDmZg.

September is Prostate Cancer Awareness Month. PSA remains a key tool in prostate cancer screening, but an elevated result does not necessarily indicate cancer. Explore how the prostate cancer screening pathway is evolving: bit.ly/4hcNgE3

Explore how molecular point-of-care testing can help improve patient flow, support antimicrobial stewardship, and strengthen care delivery across a range of clinical settings: bit.ly/4hk6TZJ

How can laboratories prevent clerical errors, learn from proficiency testing failures, and prepare new staff for PT? API Abby answers these questions and more in this installment: bit.ly/4AuYT0B

What’s on your mind as a laboratory professional? In Coaching Corner, Patty Eschliman tackles questions about compensation, leadership, workplace challenges, laboratory technology, and the changing workforce. Read her advice: bit.ly/46w9Hhw

What does it take to become an effective laboratory leader? In September’s Lab Innovator, Nancy Alers reflects on 25 years in the lab and shares lessons on leadership, quality improvement, and developing the next generation of lab leaders. bit.ly/4hiBuHa

Tomorrow: Join Dr. Olga Pozdnyakova of Penn Medicine to learn how her lab reduced unnecessary manual smear reviews using existing CBC parameters. Learn strategies to reduce workload, improve TAT & streamline hematology workflows. CE credit available: bit.ly/4i0gTJL.

A look back at the 2026 Lab Director’s Summit in Tucson! 🌵 Thanks to everyone who joined us and helped make the Summit a valuable opportunity to connect with colleagues and industry partners.